Lataa...
CDK4/6 inhibition suppresses tumour growth and enhances the effect of temozolomide in glioma cells
In adults, glioma is the most commonly occurring and invasive brain tumour. For malignant gliomas, the current advanced chemotherapy includes TMZ (temozolomide). However, a sizeable number of gliomas are unyielding to TMZ, hence, giving rise to an urgent need for more efficient treatment choices. He...
Tallennettuna:
| Julkaisussa: | J Cell Mol Med |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7205809/ https://ncbi.nlm.nih.gov/pubmed/32277580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15156 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|